Experimental Therapies

Several forms of mesothelioma treatment such as the drug Alimta, gene therapy, immunotherapy, photodynamic therapy and multimodality therapy are still in their experimental stages. We invite you to read the following articles on experimental therapies for malignant mesothelioma.

Cancer Centers

Top Cancer Centers for mesothelioma treatment have been listed alphabetically by state for your convenience. Listings include contact information and Web site links where available.

Leading Doctors

We have become familiar with medical doctors who specialize in aggressively treating malignant mesothelioma. Some of these doctors will review your medical records for free to see if you are a candidate for their mesothelioma treatment protocol.

Conventional Therapies

Conventional mesothelioma therapies include surgery, radiation and chemotherapy. You should keep in mind that if you choose one course of action for mesothelioma treatment, you may preclude other courses. All of your options should be considered as soon as possible.

Misconception

Misconception: Mesothelioma is a lung cancer.Reality: Mesothelioma is not a lung cancer but a cancer of the mesothelial cells which make up the lining of the lungs and other organs. Mesothelioma symptoms can closely mimic those of lung cancer because they affect the respiratory system much in the same way.

Misconception

Misconception: Mesothelioma is a lung cancer.Reality: Mesothelioma is not a lung cancer but a cancer of the mesothelial cells which make up the lining of the lungs and other organs. Mesothelioma symptoms can closely mimic those of lung cancer because they affect the respiratory system much in the same way.

What are Typical Patient Survival Rates Following a Mesothelioma Diagnosis?

As mesothelioma is often diagnosed in its advanced stages, the prognosis is sometimes poor with life expectancy being little more than a year following diagnosis. If diagnosed early enough however, patient prognoses increase dramatically. Patient survival rates are often contingent on the treatments available to the particular patient. Early-stage tumors eligible for surgical resection, for instance, will result in improved prognoses over those diagnosed with later-stage disease. As new therapies and treatments are researched and employed in the future, it is realistic to anticipate an improvement in patient survival rates.